Hep Email Update
MASLD Is Expected to Rise Over the Next 25 Years
An increase in fatty liver disease could double liver cancer cases and nearly triple the need for transplants by 2050.
Advertisement
CDC Supports Hepatitis C Testing for Perinatally Exposed Children
Rates of hepatitis C virus have been on the rise among pregnant women.
Food Insecure Teens Face Higher Risk of Liver Disease
Adolescents who utilized food assistance programs had better protection against liver disease.
Narcan, Now Available Without a Prescription, Can Still Be Hard to Get
At a suggested retail price of $44.99 per pack, affordability can be a barrier to access.
Is Novavax, the Latecomer COVID Vaccine, Worth the Wait?
People with long COVID and those who experienced side effects from mRNA vaccines are seeking Novavax’s protein-based offering.
Hep A Outbreaks
Our map outlines where in the United States active cases of hepatitis A have been reported in the past 12 months on a scale from 0 to 100 relative to other states.
Advertisement

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@hepmag.com. Please remember to add update@hepmag.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is:

Smart + Strong
157 Columbus Avenue, Suite 525
New York, NY 10023

Add us to your address book

Copyright (C) 2023 Smart + Strong 157 Columbus Avenue, Suite 525 New York, NY 10023 USA All rights reserved.
Terms Of Use and Your Privacy.